Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Key to changes
?
Text removedfrom 2023 Q2- Text added to 2023 Q3
Content analysis
?Positive | |
Negative | |
Uncertain | |
Constraining | |
Legalese | |
Litigous | |
Readability |
H.S. junior Avg
|
Content analysis
?Positive | |
Negative | |
Uncertain | |
Constraining | |
Legalese | |
Litigous | |
Readability |
H.S. junior Avg
|
New words:
absolute, Accurate, acknowledged, addressed, agency, analytically, antidepressant, approach, area, bipartisan, blood, brand, branding, category, certainty, clearance, codify, comment, conclusion, conflict, congressional, demonstrating, density, device, disagreed, discern, displace, disruptive, dosing, draft, drafted, drug, ESG, evidence, explained, FDA, formal, Fortune, fourth, framework, furnish, genomic, Goldman, grandfathered, Inova, installment, introduction, IVCT, Kettering, labeling, LDT, line, listing, literature, long, managerial, Memorial, metabolism, modernizing, national, notification, Onsite, oversight, paper, Partnered, pharmacogenetic, pharmacogenomic, premarket, prevail, priority, prostate, proteomic, publicly, Radiological, Raha, Ranked, rebrand, rebranded, Rebranding, relationship, renew, rulemaking, safety, Samraat, side, signaling, Sloan, smoking, solution, sought, stakeholder, unclear, USA, varying, Verifying, view, vitro, warning, writing
Valuein 2023 Q2 filing- Value in 2023 Q3 filing
Original filings
Filing view